Raymond Moore

BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.

Tanja Fehm, Brigitte Rack, Chunling Hu, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Steven N. Hart, Chunling Hu, Mark E. Robson, 2017, npj Breast Cancer.

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer

Robert Huether, Chunling Hu, Fergus J Couch, 2017, JAMA oncology.